ChimeraCore

BiotechnologySeries BSanta Barbara, USchimeracore.com

Latest round

Series B

Last raised

Dec 2007

Total raised

$5.5M

Investors

4

About ChimeraCore

ChimeraCore, Inc. is a drug delivery company focused on the development of novel targeted treatments to enhance current cancer therapies.

Who invested in ChimeraCore

4 investors across 3 rounds

See all investors in ChimeraCore

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 25, 2007

    Amount

    $4M

    Investors

    Locked

  2. Series A

    Sep 17, 2007

    Amount

    $1M

    Investors

    Locked

  3. Series B

    Sep 29, 2006

    Amount

    $0.5M

    Investors

    Locked

Questions about ChimeraCore

Who invested in ChimeraCore?

ChimeraCore has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ChimeraCore raised?

ChimeraCore has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did ChimeraCore last raise money?

ChimeraCore's most recent round on record is a Series B, in Dec 2007.

What does ChimeraCore do?

ChimeraCore is a biotechnology company.

Where is ChimeraCore headquartered?

ChimeraCore is headquartered in Santa Barbara, US.

Which VCs invest in companies like ChimeraCore?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ChimeraCore's stage. Their profiles are linked below.

Raising like ChimeraCore? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.